A non-cytolytic recombinant hiv-1 vaccine

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/48 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) C12N 7/01 (2006.01) C12N 7/04 (2006.01)

Patent

CA 2339850

A novel HIV vaccine is provided. In particular, the vaccine comprises an avirulent and non-cytolytic recombinant HIV wherein the NSS of the virus' envelope glycoprotein is replaced with a non-cytolytic signal sequence and nef gene of the virus is deleted which renders the virus avirulent.

Ce nouveau vaccin contre le virus de l'immunodéficience humaine (VIH) renferme, notamment, un VIH de recombinaison dépourvu de virulence et non cytolytique, la séquence-signal naturelle (NSS) de la glycoprotéine d'enveloppe du virus ayant été remplacée par une séquence-signal non cytolytique et le gène nef du virus ayant été délété, ce qui supprime sa virulence.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A non-cytolytic recombinant hiv-1 vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A non-cytolytic recombinant hiv-1 vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A non-cytolytic recombinant hiv-1 vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1819671

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.